A Castonguay - JoVE Visualize

Showing results (101-110 of 109) with videos related to

Pageof 11

Sort By:

You have reached the last page of results.This site can display upto 109 results.

International Journal of Oncology|May 3, 2011

Antitumorigenic and antipromoting activities of ellagic acid, ellagitannins and oligomeric anthocyanin and procyanidinA Castonguay, H Gali, E Perchellet, et al.

Advances in Therapy|October 26, 2021

Economic Evaluation of Budesonide Orodispersible Tablets for the Treatment of Eosinophilic Esophagitis: A Cost-Utility AnalysisC Beauchemin, A Castonguay, E S Chan, et al.

Current Oncology (Toronto, Ont.)|August 17, 2018

Real-world patient- and caregiver-reported outcomes in advanced breast cancerV Lambert-Obry, A Gouault-Laliberté, A Castonguay, et al.

Carcinogenesis|September 23, 1998

Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung tumor formation by FGN-1 (sulindac sulfone)A M Malkinson, K M Koski, L D Dwyer-Nield, et al.

Journal of Medicinal Chemistry|May 26, 1995

Novel inhibitors of potassium ion channels on human T lymphocytesW F Michne, J W Guiles, A M Treasurywala, et al.

Journal of Medicinal Chemistry|March 13, 2008

Conformational analysis and receptor docking of N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (taranabant, MK-0364), a novel, acyclic cannabinoid-1 receptor inverse agonistLinus S Lin, Sookhee Ha, Richard G Ball, et al.

Bioorganic & Medicinal Chemistry Letters|April 15, 2004

Bioisosteric replacement of anilide with benzoxazole: potent and orally bioavailable antagonists of VLA-4Linus S Lin, Thomas J Lanza, Laurie A Castonguay, et al.

Journal of Biomolecular Screening|April 28, 2011

Screening and identification of a novel class of TGF-β type 1 receptor kinase inhibitorQ Khai Huynh, Sarah J Wise, Keith A Koch, et al.

Biochemistry|February 13, 2003

Binding of 2-aryl-4-(piperidin-1-yl)butanamines and 1,3,4-trisubstituted pyrrolidines to human CCR5: a molecular modeling-guided mutagenesis study of the binding pocketLaurie A Castonguay, Youmin Weng, William Adolfsen, et al.

Pageof 11

Showing results (101-110 of 109) with videos related to

Sort By:

Pageof 11

You have reached the last page of results.This site can display upto 109 results.

International Journal of Oncology|May 3, 2011

Antitumorigenic and antipromoting activities of ellagic acid, ellagitannins and oligomeric anthocyanin and procyanidinA Castonguay, H Gali, E Perchellet, et al.

Advances in Therapy|October 26, 2021

Economic Evaluation of Budesonide Orodispersible Tablets for the Treatment of Eosinophilic Esophagitis: A Cost-Utility AnalysisC Beauchemin, A Castonguay, E S Chan, et al.

Current Oncology (Toronto, Ont.)|August 17, 2018

Real-world patient- and caregiver-reported outcomes in advanced breast cancerV Lambert-Obry, A Gouault-Laliberté, A Castonguay, et al.

Carcinogenesis|September 23, 1998

Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung tumor formation by FGN-1 (sulindac sulfone)A M Malkinson, K M Koski, L D Dwyer-Nield, et al.

Journal of Medicinal Chemistry|May 26, 1995

Novel inhibitors of potassium ion channels on human T lymphocytesW F Michne, J W Guiles, A M Treasurywala, et al.

Journal of Medicinal Chemistry|March 13, 2008

Conformational analysis and receptor docking of N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (taranabant, MK-0364), a novel, acyclic cannabinoid-1 receptor inverse agonistLinus S Lin, Sookhee Ha, Richard G Ball, et al.

Bioorganic & Medicinal Chemistry Letters|April 15, 2004

Bioisosteric replacement of anilide with benzoxazole: potent and orally bioavailable antagonists of VLA-4Linus S Lin, Thomas J Lanza, Laurie A Castonguay, et al.

Journal of Biomolecular Screening|April 28, 2011

Screening and identification of a novel class of TGF-β type 1 receptor kinase inhibitorQ Khai Huynh, Sarah J Wise, Keith A Koch, et al.

Biochemistry|February 13, 2003

Binding of 2-aryl-4-(piperidin-1-yl)butanamines and 1,3,4-trisubstituted pyrrolidines to human CCR5: a molecular modeling-guided mutagenesis study of the binding pocketLaurie A Castonguay, Youmin Weng, William Adolfsen, et al.

Pageof 11